propagermanium has been researched along with Diabetic Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Arai, H; Doi, T; Fukatsu, A; Iehara, N; Kanamori, H; Kita, T; Matsubara, T; Mima, A; Nagai, K; Okamoto, H; Sumi, E; Takahashi, T | 1 |
1 other study(ies) available for propagermanium and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy.
Topics: Animals; Chemokine CCL2; Diabetic Nephropathies; Germanium; Mice; Mice, Inbred ICR; Organometallic Compounds; Propionates; Receptors, CCR2; Receptors, Chemokine; Signal Transduction; Transforming Growth Factor beta1 | 2007 |